콘텐츠로 건너뛰기
Merck
모든 사진(2)

주요 문서

912298

Sigma-Aldrich

NanoFabTx microfluidic chip

for 10-30 μm particles

동의어(들):

Microfluidic kit, Microparticle, NanoFabTx, Nanoformulation

로그인조직 및 계약 가격 보기


About This Item

UNSPSC 코드:
41121800
NACRES:
NA.23

설명

Microfludic hardware kit component for synthesizing 10-30 μm microparticles

Kit components : Microfluidic chip x 1

Quality Level

응용 분야

advanced drug delivery

유사한 제품을 찾으십니까? 방문 제품 비교 안내

일반 설명

NanoFabTx microfluidic chip, for 10-30 μm particles is a component of our NanoFabTx microfluidic - micro, device kit for synthesis of 10-30 μm particles (911879). The kit additionally includes a protocol, supporting manifold, tubing, and additional accessories for microfluidic-based synthesis.

애플리케이션

NanoFabTx microfluidic chips precisely control and manipulate fluids on the microscale. Their well-controlled geometries enable facile syntheses of monodisperse polymeric microparticles. NanoFabTx microfluidic chip, for 10-30 μm particles particles can be used as a replacement for the component in our NanoFabTx microfluidic - micro, device kit for synthesis of 10-30 μm particles (911879).

법적 정보

NANOFABTX is a trademark of Sigma-Aldrich Co. LLC

가장 최신 버전 중 하나를 선택하세요:

시험 성적서(COA)

Lot/Batch Number

죄송합니다. 지금은 이 제품에 대한 COA이(가) 온라인에서 제공되지 않습니다.

도움이 필요하시면 연락하세요. 고객 지원 부서

이 제품을 이미 가지고 계십니까?

문서 라이브러리에서 최근에 구매한 제품에 대한 문서를 찾아보세요.

문서 라이브러리 방문

Andrew Gdowski et al.
Journal of nanobiotechnology, 16(1), 12-12 (2018-02-13)
The process of optimization and fabrication of nanoparticle synthesis for preclinical studies can be challenging and time consuming. Traditional small scale laboratory synthesis techniques suffer from batch to batch variability. Additionally, the parameters used in the original formulation must be
Xuanyu Li et al.
Advanced drug delivery reviews, 128, 101-114 (2017-12-27)
Microfluidic chips allow the rapid production of a library of nanoparticles (NPs) with distinct properties by changing the precursors and the flow rates, significantly decreasing the time for screening optimal formulation as carriers for drug delivery compared to conventional methods.
Samar Damiati et al.
Genes, 9(2) (2018-02-22)
Microfluidic devices present unique advantages for the development of efficient drug carrier particles, cell-free protein synthesis systems, and rapid techniques for direct drug screening. Compared to bulk methods, by efficiently controlling the geometries of the fabricated chip and the flow

자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..

고객지원팀으로 연락바랍니다.